Home >> Research Area >>MAPK Signaling>>Raf>> ML 786 dihydrochloride

ML 786 dihydrochloride

Raf kinase inhibitor CAS# 1237536-18-3

ML 786 dihydrochloride

Catalog No. BCC7997----Order now to get a substantial discount!

Product Name & Size Price Stock
ML 786 dihydrochloride: 5mg $161 In Stock
ML 786 dihydrochloride: 10mg Please Inquire In Stock
ML 786 dihydrochloride: 20mg Please Inquire Please Inquire
ML 786 dihydrochloride: 50mg Please Inquire Please Inquire
ML 786 dihydrochloride: 100mg Please Inquire Please Inquire
ML 786 dihydrochloride: 200mg Please Inquire Please Inquire
ML 786 dihydrochloride: 500mg Please Inquire Please Inquire
ML 786 dihydrochloride: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of ML 786 dihydrochloride

Number of papers citing our products

Chemical structure

ML 786 dihydrochloride

3D structure

Chemical Properties of ML 786 dihydrochloride

Cas No. 1237536-18-3 SDF Download SDF
PubChem ID 90488999 Appearance Powder
Formula C29H31Cl2F3N4O3 M.Wt 611.48
Type of Compound N/A Storage Desiccate at -20°C
Solubility Soluble to 100 mM in water and to 100 mM in DMSO
Chemical Name 3-(2-aminopropan-2-yl)-N-[(2R)-7-[(7-oxo-6,8-dihydro-5H-1,8-naphthyridin-4-yl)oxy]-1,2,3,4-tetrahydronaphthalen-2-yl]-5-(trifluoromethyl)benzamide;dihydrochloride
SMILES CC(C)(C1=CC(=CC(=C1)C(=O)NC2CCC3=C(C2)C=C(C=C3)OC4=C5CCC(=O)NC5=NC=C4)C(F)(F)F)N.Cl.Cl
Standard InChIKey DNMWHXHMDZCGEX-GHVWMZMZSA-N
Standard InChI InChI=1S/C29H29F3N4O3.2ClH/c1-28(2,33)19-11-18(12-20(15-19)29(30,31)32)27(38)35-21-5-3-16-4-6-22(14-17(16)13-21)39-24-9-10-34-26-23(24)7-8-25(37)36-26;;/h4,6,9-12,14-15,21H,3,5,7-8,13,33H2,1-2H3,(H,35,38)(H,34,36,37);2*1H/t21-;;/m1../s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of ML 786 dihydrochloride

DescriptionPotent Raf kinase inhibitor (IC50 values are 2.1, 2.5 and 4.2 nM for B-RafV600E, C-Raf and wild-type B-Raf respectively). Also inhibits Abl-1, DDR2, EPHA2 and RET tyrosine kinase activity. Inhibits pERK formation and attenuates tumor growth in melanoma cell xenografts expressing the B-RafV600E mutation in vivo. Orally bioavailable.

ML 786 dihydrochloride Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

ML 786 dihydrochloride Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of ML 786 dihydrochloride

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 1.6354 mL 8.1769 mL 16.3538 mL 32.7075 mL 40.8844 mL
5 mM 0.3271 mL 1.6354 mL 3.2708 mL 6.5415 mL 8.1769 mL
10 mM 0.1635 mL 0.8177 mL 1.6354 mL 3.2708 mL 4.0884 mL
50 mM 0.0327 mL 0.1635 mL 0.3271 mL 0.6542 mL 0.8177 mL
100 mM 0.0164 mL 0.0818 mL 0.1635 mL 0.3271 mL 0.4088 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on ML 786 dihydrochloride

IC50: 2.1, 2.5 and 4.2 nM for B-RafV600E, C-Raf and wild-type B-Raf, respectively

ML 786 is a potent Raf kinase inhibitor.

As one component of MAPK signal transduction pathway, the Raf isoform B-Raf has a high rate of activating mutation in melanoma (50-70%) and other cancers including papillary thyroid, ovarian, and colorectal. Inhibition of mutant B-Raf signaling, via either direct inhibition of the enzyme or inhibition of MEK, which is the direct substrate of Raf, has been demonstrated preclinically to inhibit tumor growth.

In vitro: ML 786 and its analog had been found to inhibit a significant number of kinases and were inhibitors of wild-type B-Raf and C-Raf. Although ML 786 and its analog displayed significant receptor tyrosine kinase activity, it was likely that such additional activity would not significantly contribute to pERK inhibition in melanoma tumors with constituitively activated B-Raf [1].

In vivo: ML 786 and its analog were found to have activity in vivo, as demonstrated by the fact that both compounds strongly inhibited the in vivo Raf pathway following a 75 or 100 mg/kg oral dose [1].

Clinical trial: N/A

Reference:
[1] Gould AE,Adams R,Adhikari S.  Design and optimization of potent and orally bioavailable tetrahydronaphthalene Raf inhibitors. J Med Chem.2011 Mar 24;54(6):1836-46.

Featured Products
New Products
  • QNZ 46

    Catalog No.:BCC6292
    CAS No.:1237744-13-6
  • Hydroxyevodiamine

    Catalog No.:BCN2491
    CAS No.:1238-43-3
  • Hopeachinol B

    Catalog No.:BCN3445
    CAS No.:1238083-45-8
  • Kazinol U

    Catalog No.:BCN4720
    CAS No.:1238116-48-7
  • UNC0321

    Catalog No.:BCC4142
    CAS No.:1238673-32-9
  • PCA 4248

    Catalog No.:BCC6699
    CAS No.:123875-01-4
  • Gentiside J

    Catalog No.:BCN7306
    CAS No.:1238837-50-7
  • Cassiaside

    Catalog No.:BCN2939
    CAS No.:123914-49-8
  • (R)-(+)-HA-966

    Catalog No.:BCC6588
    CAS No.:123931-04-4
  • Hypocrellin B

    Catalog No.:BCN3397
    CAS No.:123940-54-5
  • Topotecan

    Catalog No.:BCC5646
    CAS No.:123948-87-8
  • Decane

    Catalog No.:BCN8138
    CAS No.:124-18-5
 

References on ML 786 dihydrochloride

Design and optimization of potent and orally bioavailable tetrahydronaphthalene Raf inhibitors.[Pubmed:21341678]

J Med Chem. 2011 Mar 24;54(6):1836-46.

Inhibition of mutant B-Raf signaling, through either direct inhibition of the enzyme or inhibition of MEK, the direct substrate of Raf, has been demonstrated preclinically to inhibit tumor growth. Very recently, treatment of B-Raf mutant melanoma patients with a selective B-Raf inhibitor has resulted in promising preliminary evidence of antitumor activity. This article describes the design and optimization of tetrahydronaphthalene-derived compounds as potent inhibitors of the Raf pathway in vitro and in vivo. These compounds possess good pharmacokinetic properties in rodents and inhibit B-Raf mutant tumor growth in mouse xenograft models.

Description

Potent Raf kinase inhibitor; orally bioavailable

Keywords:

ML 786 dihydrochloride,1237536-18-3,Natural Products,Raf, buy ML 786 dihydrochloride , ML 786 dihydrochloride supplier , purchase ML 786 dihydrochloride , ML 786 dihydrochloride cost , ML 786 dihydrochloride manufacturer , order ML 786 dihydrochloride , high purity ML 786 dihydrochloride

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: